WO2010059709A9 - Metabolic syndrome and hpa axis biomarkers for major depressive disorder - Google Patents

Metabolic syndrome and hpa axis biomarkers for major depressive disorder Download PDF

Info

Publication number
WO2010059709A9
WO2010059709A9 PCT/US2009/064967 US2009064967W WO2010059709A9 WO 2010059709 A9 WO2010059709 A9 WO 2010059709A9 US 2009064967 W US2009064967 W US 2009064967W WO 2010059709 A9 WO2010059709 A9 WO 2010059709A9
Authority
WO
WIPO (PCT)
Prior art keywords
metabolic syndrome
depressive disorder
major depressive
hpa axis
axis biomarkers
Prior art date
Application number
PCT/US2009/064967
Other languages
French (fr)
Other versions
WO2010059709A2 (en
Inventor
John Bilello
Bo Pi
Original Assignee
Ridge Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ridge Diagnostics, Inc. filed Critical Ridge Diagnostics, Inc.
Priority to EP09828159A priority Critical patent/EP2356453A4/en
Priority to CN200980153799.5A priority patent/CN102301234B/en
Priority to CA2744151A priority patent/CA2744151A1/en
Priority to JP2011537577A priority patent/JP5767973B2/en
Publication of WO2010059709A2 publication Critical patent/WO2010059709A2/en
Publication of WO2010059709A9 publication Critical patent/WO2010059709A9/en
Priority to HK12106344.6A priority patent/HK1165554A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/304—Mood disorders, e.g. bipolar, depression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Primary Health Care (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PCT/US2009/064967 2008-11-18 2009-11-18 Metabolic syndrome and hpa axis biomarkers for major depressive disorder WO2010059709A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP09828159A EP2356453A4 (en) 2008-11-18 2009-11-18 Metabolic syndrome and hpa axis biomarkers for major depressive disorder
CN200980153799.5A CN102301234B (en) 2008-11-18 2009-11-18 Metabolic Syndrome And HPA Axis Biomarkers For Major Depressive Disorder
CA2744151A CA2744151A1 (en) 2008-11-18 2009-11-18 Metabolic syndrome and hpa axis biomarkers for major depressive disorder
JP2011537577A JP5767973B2 (en) 2008-11-18 2009-11-18 Metabolic syndrome biomarker and HPA axis biomarker for major depressive disorder
HK12106344.6A HK1165554A1 (en) 2008-11-18 2012-06-28 Metabolic syndrome and hpa axis biomarkers for major depressive disorder hpa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11571008P 2008-11-18 2008-11-18
US61/115,710 2008-11-18

Publications (2)

Publication Number Publication Date
WO2010059709A2 WO2010059709A2 (en) 2010-05-27
WO2010059709A9 true WO2010059709A9 (en) 2010-09-23

Family

ID=42198784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/064967 WO2010059709A2 (en) 2008-11-18 2009-11-18 Metabolic syndrome and hpa axis biomarkers for major depressive disorder

Country Status (7)

Country Link
US (2) US8440418B2 (en)
EP (1) EP2356453A4 (en)
JP (1) JP5767973B2 (en)
CN (1) CN102301234B (en)
CA (1) CA2744151A1 (en)
HK (1) HK1165554A1 (en)
WO (1) WO2010059709A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158374B1 (en) 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US20100100333A1 (en) * 2008-10-15 2010-04-22 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
US20110213219A1 (en) * 2010-01-26 2011-09-01 Ridge Diagnostics, Inc. Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
US20120178118A1 (en) * 2010-12-06 2012-07-12 Bo Pi Biomarkers for monitoring treatment of neuropsychiatric diseases
JP2012523009A (en) * 2009-04-06 2012-09-27 リッジ ダイアグノスティックス，インコーポレイテッド Biomarkers for monitoring treatment of neuropsychiatric disorders
TWI494079B (en) * 2012-12-21 2015-08-01 Univ Nat Cheng Kung Stress condition detecting apparatus
WO2015116834A1 (en) * 2014-01-29 2015-08-06 The University Of North Carolina At Chapel Hill Compositions and methods for blood biomarker analysis for predicting psychosis risk in persons with attenuated psychosis risk syndrome
WO2015174544A1 (en) * 2014-05-16 2015-11-19 国立研究開発法人国立精神・神経医療研究センター Mental illness determination marker
CN105759065B (en) * 2016-02-26 2017-10-13 天津桑尼匹克生物科技有限公司 The purposes and depression detection kit of plasma metabolism label
CN110622179A (en) * 2017-02-09 2019-12-27 科格诺亚公司 Platform and system for digital personalized medicine
CN106771113B (en) * 2017-02-27 2019-04-02 苏州市广济医院 Triglycerides is preparing application and kit in Diagnosis of Depression or curative effect evaluation kit as marker
AU2018324195A1 (en) 2017-09-01 2020-04-02 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
CN114624344A (en) * 2020-12-10 2022-06-14 中国科学院大连化学物理研究所 Steroid hormone combined biomarker and application thereof
WO2023081000A1 (en) * 2021-11-03 2023-05-11 Simbiosys, Inc. Metabolic modeling for disease prognosis and treatment

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) * 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5882203A (en) * 1995-05-31 1999-03-16 Correa; Elsa I. Method of detecting depression
US5658802A (en) * 1995-09-07 1997-08-19 Microfab Technologies, Inc. Method and apparatus for making miniaturized diagnostic arrays
NZ314144A (en) * 1996-02-02 1999-04-29 Smithkline Beecham Corp Computerised identification of at risk patients diagnosed with depression
US5804453A (en) * 1996-02-09 1998-09-08 Duan-Jun Chen Fiber optic direct-sensing bioprobe using a phase-tracking approach
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20030032773A1 (en) 2000-02-24 2003-02-13 Herath Herath Mudiyanselage Athula Chandrasiri Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
US20040110938A1 (en) * 2000-02-24 2004-06-10 Parekh Rajesh Bhikhu Proteins, genes and their use for diagnosis and treatment of schizophrenia
BR0109125A (en) * 2000-03-09 2002-11-26 Clinical Analysis Corp Medical diagnostic system
US7118710B2 (en) * 2000-10-30 2006-10-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
US20040265825A1 (en) * 2001-01-19 2004-12-30 Boris Tartakovsky Methods and compositions for diagnosing and treating a subject having depression
ATE439588T1 (en) * 2001-05-04 2009-08-15 Biosite Inc DIAGNOSTIC MARKERS FOR ACUTE HEART DISEASE AND METHODS OF USE
US6710877B2 (en) * 2001-07-23 2004-03-23 Corning Incorporated Apparatus and methods for determining biomolecular interactions
WO2003043487A2 (en) * 2001-11-19 2003-05-30 Protometrix, Inc. Method of using a non-antibody protein to detect and measure an analyte
US7136518B2 (en) * 2003-04-18 2006-11-14 Medispectra, Inc. Methods and apparatus for displaying diagnostic data
US20040152107A1 (en) * 2002-09-18 2004-08-05 C. Anthony Altar Gene signature of electroshock therapy and methods of use
KR20040032451A (en) * 2002-10-09 2004-04-17 삼성전자주식회사 Mobile device having health care function and method of health care using the same
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
WO2004059293A2 (en) * 2002-12-24 2004-07-15 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
JP2004208547A (en) 2002-12-27 2004-07-29 Hitachi Ltd Method for evaluating depression
BRPI0410296A (en) * 2003-05-06 2006-05-16 Aspect Medical Systems Inc system and method for determining the efficacy of treatment of neurological disorders using electroencephalogram
US20040228765A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20040228766A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20050084880A1 (en) * 2003-07-11 2005-04-21 Ronald Duman Systems and methods for diagnosing & treating psychological and behavioral conditions
US20070092888A1 (en) * 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof
US7394547B2 (en) * 2003-11-06 2008-07-01 Fortebio, Inc. Fiber-optic assay apparatus based on phase-shift interferometry
KR100554355B1 (en) 2003-11-26 2006-02-24 주식회사 에버케어 Apparatus and method for offering tailored health promotion service for personal
JP2005312435A (en) 2004-03-29 2005-11-10 Kazuhito Rokutan Method for evaluating depression
US20050254065A1 (en) * 2004-05-12 2005-11-17 Stokowski Stanley E Method and apparatus for detecting surface characteristics on a mask blank
KR20050115436A (en) 2004-06-02 2005-12-07 김은아 Differentially expressed genes in hippocampus of rat brain affected by repetitive transcranial magnetic stimulation (rtms) that used to the therapy for major depression
EP1766398B1 (en) * 2004-06-24 2011-01-05 GE Healthcare Bio-Sciences AB Method for detecting molecular surface interactions
US7770730B2 (en) * 2004-07-29 2010-08-10 Cook Vascular Incorporated Micropipette holder
US20060063199A1 (en) * 2004-09-21 2006-03-23 Elgebaly Salwa A Diagnostic marker
JP2008522166A (en) 2004-11-30 2008-06-26 ビージー メディスン インコーポレイテッド Biological system analysis
US7445887B2 (en) * 2005-01-07 2008-11-04 Fortebio, Inc. Enzyme activity measurements using bio-layer interferometry
AU2006220133C1 (en) * 2005-03-03 2013-01-24 Ull Meter A/S Evaluation of sympathetic tone
JP2007024822A (en) * 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd Discriminating method of male menopause or depression
WO2007058986A2 (en) 2005-11-10 2007-05-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods for diagnosing and identifying effective therapeutics for major depressive disorder
WO2007067819A2 (en) 2005-12-09 2007-06-14 Precision Human Biolaboratory Optical molecular detection
US20070161042A1 (en) * 2006-01-11 2007-07-12 Fortebio, Inc. Methods for characterizing molecular interactions
SI2006680T1 (en) 2006-02-17 2014-08-29 Atsuo Sekiyama Biological load indicator and method of measuring biological load
US20070255113A1 (en) 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
US7651836B2 (en) * 2006-08-04 2010-01-26 Hospital Santiago Apóstol Methods for diagnosis and prognostic of psychiatric diseases
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk Method for evaluation of stress, stress evaluation apparatus, stress evaluation method, stress evaluation system, stress evaluation program, and recording medium
GB0616230D0 (en) * 2006-08-16 2006-09-27 Univ Cambridge Tech Biomarkers and uses thereof
US8158374B1 (en) * 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US20080199866A1 (en) * 2006-10-10 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Snp detection and other methods for characterizing and treating bipolar disorder and other ailments
US20080281531A1 (en) * 2007-03-15 2008-11-13 Kazuhito Rokutan Method for Diagnosing Depression
US20100100333A1 (en) * 2008-10-15 2010-04-22 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
JP5663314B2 (en) * 2008-03-04 2015-02-04 リッジ ダイアグノスティックス，インコーポレイテッド Diagnosis and monitoring of depression based on multiple biomarker panels
JP5658571B2 (en) * 2008-03-12 2015-01-28 リッジ ダイアグノスティックス，インコーポレイテッド Inflammatory biomarkers for monitoring depression disorders
US20120178118A1 (en) * 2010-12-06 2012-07-12 Bo Pi Biomarkers for monitoring treatment of neuropsychiatric diseases
EP2414824B1 (en) * 2009-04-01 2017-12-06 Vindrauga Holdings, LLC Biomarkers for monitoring treatment of neuropsychiatric diseases
US20110213219A1 (en) * 2010-01-26 2011-09-01 Ridge Diagnostics, Inc. Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
JP2012523009A (en) 2009-04-06 2012-09-27 リッジ ダイアグノスティックス，インコーポレイテッド Biomarkers for monitoring treatment of neuropsychiatric disorders

Also Published As

Publication number Publication date
WO2010059709A2 (en) 2010-05-27
JP5767973B2 (en) 2015-08-26
EP2356453A2 (en) 2011-08-17
EP2356453A4 (en) 2012-08-15
US20140128273A1 (en) 2014-05-08
CN102301234B (en) 2015-06-17
US20100136700A1 (en) 2010-06-03
US8440418B2 (en) 2013-05-14
CN102301234A (en) 2011-12-28
CA2744151A1 (en) 2010-05-27
JP2012509480A (en) 2012-04-19
HK1165554A1 (en) 2012-10-05

Similar Documents

Publication Publication Date Title
WO2010059709A9 (en) Metabolic syndrome and hpa axis biomarkers for major depressive disorder
EP2266043B8 (en) Cache optimzation
AU2009246329A8 (en) Micellic assemblies
EP2335320A4 (en) Dielecrtic isolators
EP2373999A4 (en) Novel biomarkers
SG192562A1 (en) Compressor based dynamic bass enhancement with eq
EP2381243A4 (en) Analyzer
HK1150023A1 (en) Trans-clomiphene for metabolic syndrome
EP2245464A4 (en) P53 biomarkers
EP2265642A4 (en) Biomarkers
EP2293802A4 (en) Lactose compositions with decreased lactose content
EP2263086A4 (en) Biomarkers
GB0818660D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
EP2265641A4 (en) Biomarkers
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
WO2009065059A9 (en) Super-oxide dismutase mimetics
EP2302629B8 (en) Disk clamping mechanism and disk drive system
AU2009900904A0 (en) Biomarkers for chronic fatigue syndrome
AU2008906361A0 (en) Novel Biomarkers
AU2008906240A0 (en) Turntable
AU2008902126A0 (en) An improved spectrometer with self-calibration means
AU2009901771A0 (en) Biomarkers
GB0805081D0 (en) Biomarkers

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980153799.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09828159

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011537577

Country of ref document: JP

Ref document number: 2744151

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2009828159

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009828159

Country of ref document: EP